Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)
- PMID: 20146939
- PMCID: PMC4186708
- DOI: 10.1016/j.ymeth.2010.01.032
Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)
Erratum in
- Methods. 2010 Nov;52(3):268
Abstract
MicroRNAs (miRNAs) are small (approximately 22 nt) RNAs that play important roles in gene regulatory networks by binding to and repressing the activity of specific target mRNAs. Recent studies have indicated that miRNAs circulate in a stable, cell-free form in the bloodstream and that the abundance of specific miRNAs in plasma or serum can serve as biomarkers of cancer and other diseases. Measurement of circulating miRNAs as biomarkers is associated with some special challenges, including those related to pre-analytic variation and data normalization. We describe here our procedure for qRT-PCR analysis of circulating miRNAs as biomarkers, and discuss relevant issues of sample preparation, experimental design and data analysis.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
An Enhanced Quantitative Reverse Transcription-PCR Approach for Measuring Circulating MicroRNAs.Methods Mol Biol. 2024;2745:227-231. doi: 10.1007/978-1-0716-3577-3_14. Methods Mol Biol. 2024. PMID: 38060189
-
Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR.Methods Mol Biol. 2019;1881:267-276. doi: 10.1007/978-1-4939-8876-1_20. Methods Mol Biol. 2019. PMID: 30350212
-
MicroRNA profiling in plasma or serum using quantitative RT-PCR.Methods Mol Biol. 2014;1182:121-9. doi: 10.1007/978-1-4939-1062-5_11. Methods Mol Biol. 2014. PMID: 25055906
-
Free Circulating miRNAs Measurement in Clinical Settings: The Still Unsolved Issue of the Normalization.Adv Clin Chem. 2018;87:113-139. doi: 10.1016/bs.acc.2018.07.003. Epub 2018 Aug 23. Adv Clin Chem. 2018. PMID: 30342709 Free PMC article. Review.
-
Circulating microRNAs: potential biomarkers for common malignancies.Biomark Med. 2015;9(2):131-51. doi: 10.2217/bmm.14.102. Biomark Med. 2015. PMID: 25689901 Review.
Cited by
-
Tissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo.Oncotarget. 2015 Sep 8;6(26):22959-69. doi: 10.18632/oncotarget.4038. Oncotarget. 2015. PMID: 26008976 Free PMC article.
-
MicroRNAs as potential biomarkers for noninvasive detection of fetal trisomy 21.J Assist Reprod Genet. 2015 May;32(5):827-37. doi: 10.1007/s10815-015-0429-y. Epub 2015 Mar 8. J Assist Reprod Genet. 2015. PMID: 25749789 Free PMC article.
-
Identification of suitable endogenous controls for gene and miRNA expression studies in irradiated prostate cancer cells.Tumour Biol. 2015 Aug;36(8):6019-28. doi: 10.1007/s13277-015-3278-5. Epub 2015 Mar 7. Tumour Biol. 2015. PMID: 25750034
-
Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients.Oncotarget. 2015 May 30;6(15):13387-401. doi: 10.18632/oncotarget.3874. Oncotarget. 2015. PMID: 26033453 Free PMC article. Clinical Trial.
-
Circulating miR-134 is a potential biomarker for diagnosis and monitoring of major depressive disorder.Int J Clin Exp Pathol. 2020 Aug 1;13(8):2082-2091. eCollection 2020. Int J Clin Exp Pathol. 2020. Retraction in: Int J Clin Exp Pathol. 2020 Nov 01;13(11):2917. PMID: 32922604 Free PMC article. Retracted.
References
-
- Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. Cell Res. 2008;10:997–1006. - PubMed
-
- Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW, Lo YM. Clin Chem. 2008;54:482–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials